SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brad C. Dunlap who wrote (55)9/30/1996 1:11:00 AM
From: I. Luttichuys   of 1762
 
Thanks Brad! I'm Looking forward to seeing some data on durations for the RA clinicals as well as any opinions Smith Barney may have in the future (sooner rather than later I hope). I am reminded of Mr. Hecht's enthusiasm by your recent posts. It is good to hear a second opinion as informed as yours on this.
Your speculations as to the possible application of C2B8 against CLL remain interesting though you describe this as "pure speculation".
From your post I see IDEC and some oncologists find it worth exploring as well. If immunoflourescence shows less brightness for CLL CD20 I'm guessing the reduced targets for C2B8 will mean a reduced concentration of C2B8 where it is needed. The significance of this remains to be seen I suppose.
I have not been following Coulter and, as an IDEC shareholder, find your mention of HAMA response occuring during their trials another indication that I have my trust in the right place. I have yet to hear mention of much in the way of side-effects from the IDEC side and this is encouraging. I think IDEC has the more elegant/precise solution to the NHL problem and this will bode well for its preference among physicians. It comes closer to what we're all hoping for with this technology -- the desired outcome with as little undesired effect as possible.

Thanks again and have a great evening,
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News